J 0009/21 of 23.11.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:J000921.20221123
- Date of decision
- 23 November 2022
- Case number
- J 0009/21
- Petition for review of
- -
- Application number
- 09007539.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 R 142
- Application title
- Cancer therapy
- Applicant name
- Biotempus Pty Ltd
- Opponent name
- Bristol-Myers Squibb Company
- Board
- 3.1.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 20(1)European Patent Convention R 103(1)(a)European Patent Convention R 142(1)(b)European Patent Convention R 142(4)
- Keywords
- Interruption of proceedings (yes)
Patent proprietor prevented by legal reasons from continuing the proceedings (yes)
Competence of the Legal Division to declare interruption (yes)
Substantial procedural violation - reimbursement of appeal fee (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The request for reimbursement of the appeal fee is refused.